ENOV Enovis Corporation
Healthcare$24.28+0.37%ClosedMarket Cap: $1.40B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
0.61
EV/EBITDA
-14.37
DCF Value
$-111.96
FCF Yield
2.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.8%
Operating Margin
2.7%
Net Margin
-49.9%
ROE
-60.1%
ROA
-29.7%
ROIC
1.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $589.2M | 54.9% | $20.3M | $-8.8M | $— | — |
| Q4 null | $575.8M | 60.7% | $48.3M | $-520.6M | $— | — |
| FY null | $2.25B | 59.8% | $-18.9M | $-1.18B | $— | — |
| Q3 null | $548.9M | 52.2% | $9.0M | $-571.1M | $— | — |
| Q2 null | $564.5M | 59.3% | $-16.1M | $-36.7M | $— | — |
| Q1 null | $558.8M | 59.5% | $-42.9M | $-56.0M | $— | — |
| Q4 null | $561.0M | 54.8% | $-664.7M | $-703.3M | $— | — |
| FY null | $2.11B | 56.0% | $-775.7M | $-825.5M | $— | — |
| Q3 null | $505.2M | 56.7% | $-31.7M | $-31.5M | $— | — |
| Q2 null | $525.2M | 55.0% | $-44.2M | $-18.6M | $— | — |
| Q1 null | $516.3M | 57.7% | $-35.0M | $-72.0M | $— | — |
| Q4 2023 | $455.0M | 58.1% | $-5.8M | $3.0M | $0.05 | — |